Galmed Pharmaceuticals Ltd.

General ticker "GLMD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.2M (TTM average)

Galmed Pharmaceuticals Ltd. does not follow the US Stock Market performance with the rate: -5.3%.

Estimated limits based on current volatility of 4.4%: low 0.99$, high 1.08$

Factors to consider:

  • Total employees count: 15 as of 2014
  • Current price 30.1% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.62$, 5.56$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.12$, 3.96$]

Financial Metrics affecting the GLMD estimates:

  • Positive: with PPE of -0.2 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -205.69 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Positive: Shareholder equity ratio, % of 88.25 > 63.39
  • Positive: Interest expense per share per price, % of 0.52 <= 0.79

Similar symbols

Short-term GLMD quotes

Long-term GLMD plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $14.98MM $0.00MM
Operating Expenses $17.65MM $7.49MM $6.28MM
Operating Income $-17.65MM $7.49MM $-6.28MM
Non-Operating Income $-0.21MM $-14.40MM $-1.24MM
Interest Expense $0.21MM $0.01MM $0.01MM
R&D Expense $12.99MM $3.57MM $2.98MM
Income(Loss) $-17.87MM $-6.91MM $-7.52MM
Profit(Loss)* $-18.57MM $-6.91MM $-7.52MM
Stockholders Equity $13.42MM $13.88MM $16.33MM
Inventory $0.11MM $0.00MM $0.00MM
Assets $16.56MM $16.63MM $18.50MM
Operating Cash Flow $-18.50MM $-6.14MM $-5.88MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Investing Cash Flow $17.56MM $0.80MM $-1.11MM
Financing Cash Flow $0.07MM $6.18MM $8.79MM
Earnings Per Share** $-11.08 $-30.05 $-8.08

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.